342P - Response to primary treatment for first recurrence independently influences survival of patients with hormone receptor-positive, HER2-negative breast cancer: A multicenter study of 236 recurrent metastatic patients
| Autor: | Yamamura, J., Kamigaki, S., Tsujie, M., Fujita, J., Osato, H., Higashi, C., Kanaizumi, H., Tanaka, Y., Hamada, M., Shinzaki, W., Hasimoto, Y., Komoike, Y. |
|---|---|
| Zdroj: | In Annals of Oncology October 2018 29 Supplement 8 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|